Jump to content

Ning Zheng: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Citation bot (talk | contribs)
Altered date. Add: bibcode, pmid, authors 1-1. Removed parameters. Some additions/deletions were parameter name changes. | Use this bot. Report bugs. | Suggested by LeapTorchGear | Category:AfC pending submissions by age/0 days ago | #UCB_Category 38/121
mNo edit summary
Line 5: Line 5:
{{AfC submission|t||ts=20240524145629|u=TheScienceContributor|ns=118|demo=}}<!-- Important, do not remove this line before article has been created. -->
{{AfC submission|t||ts=20240524145629|u=TheScienceContributor|ns=118|demo=}}<!-- Important, do not remove this line before article has been created. -->


'''Ning Zheng''' is an experimental structural biologist known for his pioneering work in the field of [[Molecular glue|molecular glues]]. He is currently a professor in the Department of Pharmacology at the [[University of Washington School of Medicine]] and a [[Howard Hughes Medical Institute|Howard Hughes Medical Institute (HHMI)]] Investigator. <ref>{{Cite web |title=Ning Zheng |url=https://pharmacology.uw.edu/team-member/ning-zheng/ |access-date=2024-05-24 |website=UW Pharmacology |language=en-US}}</ref><ref>{{Cite web |title=Ning Zheng, PhD {{!}} Investigator Profile {{!}} 2008-Present |url=https://www.hhmi.org/scientists/ning-zheng |access-date=2024-05-24 |website=www.hhmi.org |language=en}}</ref>
'''Ning Zheng''' is an experimental structural biologist and protein biochemist known for his pioneering work in the fields of [[Molecular glue|molecular glues]] and targeted [[Proteolysis|protein degradation]]. He is currently a professor in the Department of Pharmacology at the [[University of Washington School of Medicine]] and a [[Howard Hughes Medical Institute|Howard Hughes Medical Institute (HHMI)]] Investigator. <ref name=":1">{{Cite web |title=Ning Zheng |url=https://pharmacology.uw.edu/team-member/ning-zheng/ |access-date=2024-05-24 |website=UW Pharmacology |language=en-US}}</ref><ref>{{Cite web |title=Ning Zheng, PhD {{!}} Investigator Profile {{!}} 2008-Present |url=https://www.hhmi.org/scientists/ning-zheng |access-date=2024-05-24 |website=www.hhmi.org |language=en}}</ref>


=== Education and training ===
=== Education and training ===
Ning Zheng obtained his Ph.D. in 1997 from the [[University of Texas Southwestern Medical Center]]. He completed his postdoctoral studies at the [[Memorial Sloan Kettering Cancer Center|Memorial Sloan-Kettering Cancer Center]] under the mentorship of [[Nikola Pavletich]], where he published two seminal studies on the atomic structures of prototypical human ubiquitin ligase complexes.<ref>{{Cite journal |last1=Zheng |first1=Ning |last2=Schulman |first2=Brenda A. |last3=Song |first3=Langzhou |last4=Miller |first4=Julie J. |last5=Jeffrey |first5=Philip D. |last6=Wang |first6=Ping |last7=Chu |first7=Claire |last8=Koepp |first8=Deanna M. |last9=Elledge |first9=Stephen J. |last10=Pagano |first10=Michele |last11=Conaway |first11=Ronald C. |last12=Conaway |first12=Joan W. |last13=Harper |first13=J. Wade |last14=Pavletich |first14=Nikola P. |date=April 2002 |title=Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex |url=https://www.nature.com/articles/416703a |journal=Nature |language=en |volume=416 |issue=6882 |pages=703–709 |doi=10.1038/416703a |pmid=11961546 |issn=1476-4687}}</ref><ref>{{Cite journal |last1=Goldenberg |first1=Seth J. |last2=Cascio |first2=Thomas C. |last3=Shumway |first3=Stuart D. |last4=Garbutt |first4=Kenneth C. |last5=Liu |first5=Jidong |last6=Xiong |first6=Yue |last7=Zheng |first7=Ning |date=November 2004 |title=Structure of the Cand1-Cul1-Roc1 Complex Reveals Regulatory Mechanisms for the Assembly of the Multisubunit Cullin-Dependent Ubiquitin Ligases |url=https://doi.org/10.1016/j.cell.2004.10.019 |journal=Cell |volume=119 |issue=4 |pages=517–528 |doi=10.1016/j.cell.2004.10.019 |pmid=15537541 |issn=0092-8674}}</ref> These studies laid the foundation for his subsequent research and contributions to structural biology and protein [[Ubiquitin|ubiquitination]].
Ning Zheng obtained his Ph.D. in 1997 from the [[University of Texas Southwestern Medical Center]]. He completed his postdoctoral studies at the [[Memorial Sloan Kettering Cancer Center|Memorial Sloan-Kettering Cancer Center]] under the mentorship of [[Nikola Pavletich]], where he published two seminal studies on the atomic structures of prototypical human ubiquitin ligase complexes.<ref>{{Cite journal |last1=Zheng |first1=Ning |last2=Schulman |first2=Brenda A. |last3=Song |first3=Langzhou |last4=Miller |first4=Julie J. |last5=Jeffrey |first5=Philip D. |last6=Wang |first6=Ping |last7=Chu |first7=Claire |last8=Koepp |first8=Deanna M. |last9=Elledge |first9=Stephen J. |last10=Pagano |first10=Michele |last11=Conaway |first11=Ronald C. |last12=Conaway |first12=Joan W. |last13=Harper |first13=J. Wade |last14=Pavletich |first14=Nikola P. |date=April 2002 |title=Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex |url=https://www.nature.com/articles/416703a |journal=Nature |language=en |volume=416 |issue=6882 |pages=703–709 |doi=10.1038/416703a |pmid=11961546 |issn=1476-4687}}</ref><ref>{{Cite journal |last1=Goldenberg |first1=Seth J. |last2=Cascio |first2=Thomas C. |last3=Shumway |first3=Stuart D. |last4=Garbutt |first4=Kenneth C. |last5=Liu |first5=Jidong |last6=Xiong |first6=Yue |last7=Zheng |first7=Ning |date=November 2004 |title=Structure of the Cand1-Cul1-Roc1 Complex Reveals Regulatory Mechanisms for the Assembly of the Multisubunit Cullin-Dependent Ubiquitin Ligases |url=https://doi.org/10.1016/j.cell.2004.10.019 |journal=Cell |volume=119 |issue=4 |pages=517–528 |doi=10.1016/j.cell.2004.10.019 |pmid=15537541 |issn=0092-8674}}</ref> These studies laid the foundation for his subsequent research and contributions to [[structural biology]] and protein [[ubiquitination]].


=== Research ===
=== Research ===
Ning Zheng’s research focuses on the molecular and structural mechanisms by which protein-protein interactions regulate eukaryotic biology and human diseases. His laboratory has significantly contributed to understanding the cullin-RING superfamily of [[E3 Ubiquitin Ligase|E3 ubiquitin ligases]], which is implicated in various cellular functions such as [[signal transduction]], [[Cell cycle|cell cycle regulation]], [[Transcriptional regulation|transcriptional control]], and [[DNA repair]].<ref name=":0">{{Cite web |title=Ning Zheng Laboratory at the University of Washington |url=https://depts.washington.edu/zhenglab/ |access-date=2024-05-24 |website=depts.washington.edu}}</ref>
Ning Zheng’s research focuses on the molecular and structural mechanisms by which protein-protein interactions regulate eukaryotic biology and human diseases. His laboratory has made significant contributions to understanding the cullin-RING superfamily of [[E3 Ubiquitin Ligase|E3 ubiquitin ligases]], which is implicated in a myriad of cellular functions such as [[signal transduction]], [[Cell cycle|cell cycle regulation]], [[Transcriptional regulation|transcriptional control]], and [[DNA repair]].<ref name=":0">{{Cite web |title=Ning Zheng Laboratory at the University of Washington |url=https://depts.washington.edu/zhenglab/ |access-date=2024-05-24 |website=depts.washington.edu}}</ref>


Zheng's recent studies have expanded to several areas of life sciences, including [[Proteolysis|protein degradation]], plant hormone signaling, [[circadian clock]] regulation, chromatin modification, and the structure-function relationships of [[Ion channel|ion channels]] and transporters.<ref name=":0" /> His groundbreaking work on the perception mechanism of the plant hormone [[auxin]] led to the introduction of the concept of "[[molecular glue]]." <ref>{{Cite journal |last1=Tan |first1=Xu |last2=Calderon-Villalobos |first2=Luz Irina A. |last3=Sharon |first3=Michal |last4=Zheng |first4=Changxue |last5=Robinson |first5=Carol V. |last6=Estelle |first6=Mark |last7=Zheng |first7=Ning |date=2007-04-05 |title=Mechanism of auxin perception by the TIR1 ubiquitin ligase |url=https://pubmed.ncbi.nlm.nih.gov/17410169 |journal=Nature |volume=446 |issue=7136 |pages=640–645 |doi=10.1038/nature05731 |issn=1476-4687 |pmid=17410169|bibcode=2007Natur.446..640T }}</ref> This concept describes how small molecules can promote protein-protein interactions by complementing protein interfaces, facilitating targeted-protein degradation.<ref>{{Cite journal |title=Molecular glue binds protein degradation experts together |url=https://www.nature.com/articles/d43747-023-00040-0 |language=en}}</ref> This idea has become instrumental in the development of novel therapeutic compounds for targeting disease-causing proteins considered undruggable.<ref>{{Cite journal |last=Garber |first=Ken |date=2024-04-01 |title=The glue degraders |url=https://www.nature.com/articles/s41587-024-02164-9 |journal=Nature Biotechnology |language=en |volume=42 |issue=4 |pages=546–550 |doi=10.1038/s41587-024-02164-9 |pmid=38448663 |issn=1546-1696}}</ref> His laboratory is actively involved in drug discovery programs aimed at treating challenging human diseases, such as cancers and neurodegenerative disorders.<ref name=":0" />
Zheng's recent studies have expanded to several areas of life sciences, including [[Proteolysis|protein degradation]], plant hormone signaling, [[circadian clock]] regulation, chromatin modification, and the structure-function relationships of [[Ion channel|ion channels]] and transporters.<ref name=":0" /> His groundbreaking work on the perception mechanism of the plant hormone [[auxin]] led to the introduction of the concept of "[[molecular glue]]." <ref>{{Cite journal |last1=Tan |first1=Xu |last2=Calderon-Villalobos |first2=Luz Irina A. |last3=Sharon |first3=Michal |last4=Zheng |first4=Changxue |last5=Robinson |first5=Carol V. |last6=Estelle |first6=Mark |last7=Zheng |first7=Ning |date=2007-04-05 |title=Mechanism of auxin perception by the TIR1 ubiquitin ligase |url=https://pubmed.ncbi.nlm.nih.gov/17410169 |journal=Nature |volume=446 |issue=7136 |pages=640–645 |doi=10.1038/nature05731 |issn=1476-4687 |pmid=17410169|bibcode=2007Natur.446..640T }}</ref> This concept describes how monovalent small molecules can promote protein-protein interactions by complementing protein interfaces, facilitating targeted-protein degradation.<ref>{{Cite journal |title=Molecular glue binds protein degradation experts together |url=https://www.nature.com/articles/d43747-023-00040-0 |language=en}}</ref> This conceptual advance has become instrumental in the development of novel therapeutic compounds for targeting disease-causing proteins considered undruggable.<ref>{{Cite journal |last=Garber |first=Ken |date=2024-04-01 |title=The glue degraders |url=https://www.nature.com/articles/s41587-024-02164-9 |journal=Nature Biotechnology |language=en |volume=42 |issue=4 |pages=546–550 |doi=10.1038/s41587-024-02164-9 |pmid=38448663 |issn=1546-1696}}</ref> His laboratory is actively involved in drug discovery programs aimed at treating challenging human diseases, such as [[Cancer|cancers]] and [[Neurodegenerative disease|neurodegenerative disorders]].<ref name=":0" />


=== Awards and recognition ===
=== Awards and recognition ===
Throughout his career, Ning Zheng has received numerous accolades. After joining the faculty of Pharmacology at the [[University of Washington]], he was awarded the [[Pew Scholar]] Award and the [[Burroughs Wellcome Fund|Burroughs Welcome]] Investigator Award in Pathogenesis of Infectious Diseases.<ref>{{Cite web |title=Pew Biomedical Scholars |url=https://www.pewtrusts.org/en/projects/pew-biomedical-scholars/directory-of-pew-scholars/2004/ning-zheng }}</ref><ref>{{Cite web |title=Grant Recipients |url=https://www.bwfund.org/funding-opportunities/infectious-diseases/investigators-in-the-pathogenesis-of-infectious-disease/grant-recipients/ |access-date=2024-05-24 |website=Burroughs Wellcome Fund |language=en-US}}</ref> In 2008, he became a [[Howard Hughes Medical Institute]] Investigator, and in 2012, he was promoted to Professor.<ref>{{Cite web |title=Ning Zheng, PhD {{!}} Investigator Profile {{!}} 2008-Present |url=https://www.hhmi.org/scientists/ning-zheng |access-date=2024-05-24 |website=www.hhmi.org |language=en}}</ref> His significant contributions to science have been recognized through his election as a Fellow of the [[American Association for the Advancement of Science|American Association for the Advancement of Science (AAAS)]] in 2015 and as a member of the Washington State Academy of Science in 2020.<ref>{{Cite web |title=AAAS names four UW researchers as fellows |url=https://www.washington.edu/news/2015/11/23/aaas-names-four-uw-researchers-as-fellows/ |access-date=2024-05-24 |website=UW News |language=en}}</ref><ref>{{Cite web |title=7 University of Washington researchers elected to the Washington State Academy of Sciences in 2020 |url=https://www.washington.edu/news/2020/07/16/wsas-2020/ |access-date=2024-05-24 |website=UW News |language=en}}</ref>
Throughout his career, Ning Zheng has received numerous accolades. After joining the faculty of Pharmacology at the [[University of Washington]], he was awarded the [[Pew Scholar]] Award and the [[Burroughs Wellcome Fund|Burroughs Welcome]] Investigator Award in Pathogenesis of Infectious Diseases.<ref>{{Cite web |title=Pew Biomedical Scholars |url=https://www.pewtrusts.org/en/projects/pew-biomedical-scholars/directory-of-pew-scholars/2004/ning-zheng }}</ref><ref>{{Cite web |title=Grant Recipients |url=https://www.bwfund.org/funding-opportunities/infectious-diseases/investigators-in-the-pathogenesis-of-infectious-disease/grant-recipients/ |access-date=2024-05-24 |website=Burroughs Wellcome Fund |language=en-US}}</ref> In 2008, he became a [[Howard Hughes Medical Institute]] Investigator.<ref>{{Cite web |title=Ning Zheng, PhD {{!}} Investigator Profile {{!}} 2008-Present |url=https://www.hhmi.org/scientists/ning-zheng |access-date=2024-05-24 |website=www.hhmi.org |language=en}}</ref> He was promoted to Professor in 2012.<ref name=":1" /><ref>{{Cite web |title=Participating Faculty |url=https://depts.washington.edu/bpsd/people/faculty/entry/nzheng/ |access-date=2024-05-25 |website=UW Biological Physics, Structure and Design |language=en-US}}</ref> His significant contributions to science have been recognized through his election as a Fellow of the [[American Association for the Advancement of Science|American Association for the Advancement of Science (AAAS)]] in 2015 and as a member of the Washington State Academy of Science in 2020.<ref>{{Cite web |title=AAAS names four UW researchers as fellows |url=https://www.washington.edu/news/2015/11/23/aaas-names-four-uw-researchers-as-fellows/ |access-date=2024-05-24 |website=UW News |language=en}}</ref><ref>{{Cite web |title=7 University of Washington researchers elected to the Washington State Academy of Sciences in 2020 |url=https://www.washington.edu/news/2020/07/16/wsas-2020/ |access-date=2024-05-24 |website=UW News |language=en}}</ref>


=== Selected publications ===
=== Selected publications ===

Revision as of 10:54, 25 May 2024

Ning Zheng is an experimental structural biologist and protein biochemist known for his pioneering work in the fields of molecular glues and targeted protein degradation. He is currently a professor in the Department of Pharmacology at the University of Washington School of Medicine and a Howard Hughes Medical Institute (HHMI) Investigator. [1][2]

Education and training

Ning Zheng obtained his Ph.D. in 1997 from the University of Texas Southwestern Medical Center. He completed his postdoctoral studies at the Memorial Sloan-Kettering Cancer Center under the mentorship of Nikola Pavletich, where he published two seminal studies on the atomic structures of prototypical human ubiquitin ligase complexes.[3][4] These studies laid the foundation for his subsequent research and contributions to structural biology and protein ubiquitination.

Research

Ning Zheng’s research focuses on the molecular and structural mechanisms by which protein-protein interactions regulate eukaryotic biology and human diseases. His laboratory has made significant contributions to understanding the cullin-RING superfamily of E3 ubiquitin ligases, which is implicated in a myriad of cellular functions such as signal transduction, cell cycle regulation, transcriptional control, and DNA repair.[5]

Zheng's recent studies have expanded to several areas of life sciences, including protein degradation, plant hormone signaling, circadian clock regulation, chromatin modification, and the structure-function relationships of ion channels and transporters.[5] His groundbreaking work on the perception mechanism of the plant hormone auxin led to the introduction of the concept of "molecular glue." [6] This concept describes how monovalent small molecules can promote protein-protein interactions by complementing protein interfaces, facilitating targeted-protein degradation.[7] This conceptual advance has become instrumental in the development of novel therapeutic compounds for targeting disease-causing proteins considered undruggable.[8] His laboratory is actively involved in drug discovery programs aimed at treating challenging human diseases, such as cancers and neurodegenerative disorders.[5]

Awards and recognition

Throughout his career, Ning Zheng has received numerous accolades. After joining the faculty of Pharmacology at the University of Washington, he was awarded the Pew Scholar Award and the Burroughs Welcome Investigator Award in Pathogenesis of Infectious Diseases.[9][10] In 2008, he became a Howard Hughes Medical Institute Investigator.[11] He was promoted to Professor in 2012.[1][12] His significant contributions to science have been recognized through his election as a Fellow of the American Association for the Advancement of Science (AAAS) in 2015 and as a member of the Washington State Academy of Science in 2020.[13][14]

Selected publications

External Links

References

  1. ^ a b "Ning Zheng". UW Pharmacology. Retrieved 2024-05-24.
  2. ^ "Ning Zheng, PhD | Investigator Profile | 2008-Present". www.hhmi.org. Retrieved 2024-05-24.
  3. ^ Zheng, Ning; Schulman, Brenda A.; Song, Langzhou; Miller, Julie J.; Jeffrey, Philip D.; Wang, Ping; Chu, Claire; Koepp, Deanna M.; Elledge, Stephen J.; Pagano, Michele; Conaway, Ronald C.; Conaway, Joan W.; Harper, J. Wade; Pavletich, Nikola P. (April 2002). "Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex". Nature. 416 (6882): 703–709. doi:10.1038/416703a. ISSN 1476-4687. PMID 11961546.
  4. ^ Goldenberg, Seth J.; Cascio, Thomas C.; Shumway, Stuart D.; Garbutt, Kenneth C.; Liu, Jidong; Xiong, Yue; Zheng, Ning (November 2004). "Structure of the Cand1-Cul1-Roc1 Complex Reveals Regulatory Mechanisms for the Assembly of the Multisubunit Cullin-Dependent Ubiquitin Ligases". Cell. 119 (4): 517–528. doi:10.1016/j.cell.2004.10.019. ISSN 0092-8674. PMID 15537541.
  5. ^ a b c "Ning Zheng Laboratory at the University of Washington". depts.washington.edu. Retrieved 2024-05-24.
  6. ^ Tan, Xu; Calderon-Villalobos, Luz Irina A.; Sharon, Michal; Zheng, Changxue; Robinson, Carol V.; Estelle, Mark; Zheng, Ning (2007-04-05). "Mechanism of auxin perception by the TIR1 ubiquitin ligase". Nature. 446 (7136): 640–645. Bibcode:2007Natur.446..640T. doi:10.1038/nature05731. ISSN 1476-4687. PMID 17410169.
  7. ^ "Molecular glue binds protein degradation experts together". {{cite journal}}: Cite journal requires |journal= (help)
  8. ^ Garber, Ken (2024-04-01). "The glue degraders". Nature Biotechnology. 42 (4): 546–550. doi:10.1038/s41587-024-02164-9. ISSN 1546-1696. PMID 38448663.
  9. ^ "Pew Biomedical Scholars".
  10. ^ "Grant Recipients". Burroughs Wellcome Fund. Retrieved 2024-05-24.
  11. ^ "Ning Zheng, PhD | Investigator Profile | 2008-Present". www.hhmi.org. Retrieved 2024-05-24.
  12. ^ "Participating Faculty". UW Biological Physics, Structure and Design. Retrieved 2024-05-25.
  13. ^ "AAAS names four UW researchers as fellows". UW News. Retrieved 2024-05-24.
  14. ^ "7 University of Washington researchers elected to the Washington State Academy of Sciences in 2020". UW News. Retrieved 2024-05-24.